Hepatic fibrosis is enhanced and accompanied by robust oval cell activation following chronic carbon tetrachloride administration to Egr-1-deficient mice. Am J Pathol. 2010; 176:2743752. [PubMed: 20395449] 37. Saihan EM, Burton JL, Heaton KW. A brand new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud’s phenomenon and peripheral neuropathy. Br J Dermatol. 1978; 99:437440. [PubMed: 213095] 38. Selgrade MK, Gilmour MI. Suppression of pulmonary host defenses and enhanced susceptibility to respiratory bacterial infection in mice following inhalation exposure to trichloroethylene and chloroform. J Immunotoxicol. 2010; 7:35056. [PubMed: 20925451] 39. Toda I, Sullivan BD, Rocha EM, Da Silveira LA, Wickham LA, Sullivan DA.PS10 Effect of gender on exocrine gland inflammation in mouse models of Sjogren’s syndrome. Exp Eye Res. 1999; 69:35566. [PubMed: 10504269] 40. Tovey MG, Gugenheim J, Guymarho J, Blanchard B, Vanden Broecke C, Gresser I, Bismuth H, Reynes M. Genes for interleukin-1, interleukin-6, and tumor necrosis aspect are expressed at markedly decreased levels inside the livers of individuals with severe liver disease. Autoimmunity. 1991; ten:29710. [PubMed: 1772964] 41. Wallenius V, Wallenius K, Hisaoka M, Sandstedt J, Ohlsson C, Kopf M, Jansson JO. Retarded liver development in interleukin-6-deficient and tumor necrosis element receptor-1-deficient mice. Endocrinology. 2001; 142:2953960. [PubMed: 11416016] 42. Wang G, Cai P, Ansari GA, Khan MF. Oxidative and nitrosative tension in trichloroethene-mediated autoimmune response. Toxicology. 2007; 229:18693. [PubMed: 17123686] 43. Wang G, Wang J, Ma H, Ansari GA, Khan MF. N-Acetylcysteine protects against trichloroethenemediated autoimmunity by attenuating oxidative pressure. Toxicol Appl Pharmacol. 2013; 273:189195. [PubMed: 23993974] 44. Weller M, Stevens A, Sommer N, Melms A, Dichgans J, Wietholter H. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological issues. J Neurol Sci. 1991; 104:21521. [PubMed: 1940975] 45. Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, Manns MP, Muller W, Trautwein C. Interleukin-6/glycoprotein 130-dependent pathways are protective for the duration of liver regeneration.BMS-986278 J Biol Chem.PMID:25023702 2003; 278:112811288. [PubMed: 12509437] 46. Wunderlich FT, Strohle P, Konner AC, Gruber S, Tovar S, Bronneke HS, Juntti-Berggren L, Li LS, van RN, Libert C, Berggren PO, Bruning JC. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab. 2010; 12:23749. [PubMed: 20816090] 47. Yanez Diaz S, Moran M, Unamuno P, Armijo M. Silica and trichloroethylene-induced progressive systemic sclerosis. Dermatol. 1992; 184:9802. 48. Yoshida A, Hosokawa T, Nishi Y, Koyama K, Nakamura K, Marui N, Rokutan K, Aoike A, Kawai K. Research on age-related functional alterations in regulatory T cells and B cells involved in the autoantibody production of MRL/MpJ- +/+ mice. Mech Ageing Dev. 1989; 50:17992. [PubMed: 2601416] 49. Zhang J, Xie S, Ma W, Teng Y, Tian Y, Huang X, Zhang Y. A newly identified microRNA, mmumiR-7578, functions as a adverse regulator on inflammatory cytokines tumor necrosis factoralpha and interleukin-6 by means of targeting Egr1 in vivo. J Biol Chem. 2013; 288:4310320. [PubMed: 23184950] 50. Zhang W, Tsuda M, Yang GX, Tsuneyama K, Rong G, Ridgway WM, Ansari AA, Flavell RA, Coppel RL, Lian ZX, Gershwin ME. Deletion of interleukin-6 in mice with the dominant damaging kind of transforming gro.